Invited commentary: lipoproteins and dementia - is it the apolipoprotein A-I?

Am J Epidemiol. 2007 May 1;165(9):993-7. doi: 10.1093/aje/kwm033. Epub 2007 Feb 13.

Abstract

Because of the aging of the population, dementia has become a major public health problem. There has been growing evidence for a possible association between lipids and dementia. A large body of literature has demonstrated multiple hypothesized biologic links between lipids and neurodegenerative or other biologic pathways connected to dementing processes. However, the epidemiologic associations have been conflicting: dyslipidemia at middle age, but not in later life, seems to be associated with higher dementia risk in some but not all studies. Results from the Honolulu-Asia Aging Study reported by Saczynski et al. (Am J Epidemiol 2007;165:985-92) suggest that lipoprotein constituents, such as apolipoprotein A-I, a major component of the high density lipoprotein, may be more informative in enlightening the association between lipids and dementia. In this commentary, the epidemiology and biology of apolipoprotein A-I in relation to dementia is reviewed.

Publication types

  • Comment

MeSH terms

  • Aging / genetics
  • Apolipoprotein A-I / blood*
  • Apolipoprotein A-I / genetics
  • Cholesterol, HDL / blood
  • Dementia / epidemiology
  • Dementia / physiopathology*
  • Humans
  • Inflammation / physiopathology
  • Lipoproteins / blood
  • Lipoproteins / genetics
  • Risk Factors

Substances

  • Apolipoprotein A-I
  • Cholesterol, HDL
  • Lipoproteins